Atenolol and Anion gap increased - a phase IV clinical study of FDA data

Summary:

Anion gap increased is reported as a side effect among people who take Atenolol (atenolol), especially for people who are female, 60+ old, also take Lisinopril, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Anion gap increased when taking Atenolol. It is created by eHealthMe based on reports of 170,420 people who have side effects when taking Atenolol from the FDA, and is updated regularly.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 176,618 Atenolol users. Check the latest studies of Atenolol.

What is Anion gap increased?

Anion gap increased is found to be associated with 249 drugs and 396 conditions by eHealthMe. Check the latest studies of Anion gap increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

170,420 people reported to have side effects when taking Atenolol.
Among them, 44 people (0.03%) have Anion gap increased.

Could Atenolol cause Anion gap increased?

Among these 44 people:

What is the gender of people who have Anion gap increased when taking Atenolol? *

female: 57.5 %
male: 42.5 %

What is the age of people who have Anion gap increased when taking Atenolol? *

What are other drugs people take besides Atenolol? *

What are other side effects people have besides Anion gap increased? *

Acute Kidney Failure: 29 people, 65.91%
Lactic Acidosis (low ph in body tissues): 19 people, 43.18%
Hyperkalemia (damage to or disease of the kidney): 15 people, 34.09%
Blood Creatinine Increased: 14 people, 31.82%
Fatigue (feeling of tiredness): 14 people, 31.82%
Hypotension (abnormally low blood pressure): 12 people, 27.27%
Blood Glucose Increased: 10 people, 22.73%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 9 people, 20.45%
Blood Urea Increased: 8 people, 18.18%
Confusional State: 7 people, 15.91%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 11.36%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 6.82%
Diabetes: 3 people, 6.82%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.82%
Stress And Anxiety: 2 people, 4.55%
Psychotic Disorder: 2 people, 4.55%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.27%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 2.27%
Cardiac Disorder: 1 person, 2.27%
Constipation: 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Atenolol and have Anion gap increased?

- Check whether Anion gap increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atenolol:

Atenolol (176,618 reports)

Browse all side effects of Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anion gap increased:

Anion gap increased (249 drugs)

Browse all the conditions that are associated with Anion gap increased:

Anion gap increased (396 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atenolol (the active ingredients of Atenolol) and Atenolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.